Mark hoffman, vice president, LifeSciences Solutions, is responsible for Cerner’s LifeSciences development initiatives, including genomics, clinical trials, Galt, and the Cerner Discovere™ and HIV Insight® solutions. In his current role, Hoffman is charged with reducing the barriers between patient care and clinical research and enhancing Cerner’s role in the pharmaceutical industry. Hoffman serves as a member of the Evaluating Genomics Applications in Practice and Prevention (EGAPP) Stakeholder group, for which he is co-chair of the informatics sub-committee. He also is a member of the RAND Corp. initiative on genetic test reporting. He recently served on the Secretary of HHS Advisory Committee on Genomics Health and Society (SACGHS) task force on Genetic Testing Oversight and contributed to the informatics chapter of the task force report. Hoffman earned a bachelor’s degree in molecular biology from William Jewell College in Liberty, Mo., and a Ph.D. in bacteriology from the University of Wisconsin-Madison. He also completed a bioethics study from Oxford University while at William Jewell.